You are here

Health Care & Law

The FDA’s New Guidance for Off-Label Promotion Is Only a Start

Robert I. Field, JD, MPH, PhD
PDF version: 
Dr. Field presents the case for and against the FDA’s proposed new limits for pharmaceutical manufacturers in marketing and promoting off-label uses of drugs.